Tran Van Hiep

Mr. Tran Van Hiep

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
TPThu Thao Pham
Thu Thao Pham
HTHuyen Nguyen Thanh
Huyen Nguyen Thanh
LOLe Hong Oanh
Le Hong Oanh
TLTran Lam
Tran Lam
THTran Van Hiep
Tran Van Hiep
Nguyen Thi Phuong TrangNguyen Thi Phuong Trang
Nguyen Thi Phuong Trang
Pseudomonas aeruginosa is a clinically significant pathogen with high antibiotic resistance, necessitating rapid and reliable diagnostic methods. In this study, we employed a whole-cell SELEX strategy to select ssDNA aptamers that specifically recognize P. aeruginosa. After 10 selection rounds, six aptamer candidates were obtained and evaluated for affinity. To demonstrate the diagnostic potential, aptamer T1 was integrated into a hybrid lateral flow immunoassay (LFIA), replacing the traditional detection antibody. In this assay, the AuNP–aptamer complex interacts with the target bacteria and is captured by a specific antibody immobilized on the test line. The LFA achieved a visual detection limit of ~102 CFU/mL within 15 minutes, demonstrating high specificity and potential for point-of-care applications. This study highlights the feasibility of using aptamers as low-cost, rapidly synthesized recognition elements in bacterial diagnostics and lays the groundwork for aptamer-based biosensor development for other infectious agents.

30 March 2024 in Vietnam Journal of Biotechnology
Verified
Journal Article
Open access
PDF file
TTThao Chu Thi
Thao Chu Thi
LTLiem Nguyen Thanh
Liem Nguyen Thanh
BABui Viet Anh
Bui Viet Anh
THTran Van Hiep
Tran Van Hiep
LTLy Thi Bich Thuy
Ly Thi Bich Thuy
NNNam Nguyen
Nam Nguyen
Cord blood has emerged as a valuable and versatile resource, holding within its grasp a myriad of immune and stem cell types with immense therapeutic potential. Moreover, immune profiling in cord blood, a burgeoning field of research, offers profound insight into the early immune development of newborns, paving the way for understanding immune health, disease susceptibility, and therapeutic interventions. Therefore, in this research, we aimed to characterize the diverse immune and stem cell types present in the cord blood of Vietnamese infants. In this study, a total of 59 cord blood samples were examined for immune cell populations. Cell populations were identified using flow cytometry based on the expression of specific markers on the cell surface. The results showed that the CD3+/CD4+ population accounted for the greatest proportion of lymphocytes (46.71 ± 8.99%), followed by the CD3+/CD8+ population (22.58 ± 6.73%). The mature B-cell population (CD3-/CD19+) accounted for 9.52 ± 3.28%, while CD3+/CD19+ cells accounted for an average of 8.59 ± 5.77%. Moreover, the NK population (CD3-/CD56+ cells) accounted for 6.44 ± 4.9%, T lymphocytes carrying both CD4 and CD8 markers (CD3+/CD4+/CD8+) accounted for 0.63 ± 0.41%, and NKT cells (CD3+/CD56+) accounted for only 0.30 ± 0.53%. Moreover, the number of hematopoietic stem cells (HSCs) tends to increase in umbilical cord blood units with a high volume and number of TNCs and MNCs. In contrast, the number of HSCs was negatively correlated with the ratio of B lymphocytes. The TCD4 ratio was positively correlated with the number of HSCs but negatively correlated with the NK ratio (p = 0.01). The study initially characterized the diversity of some stem and immune cell types present in the umbilical cord blood of Vietnamese infants. These findings laid the groundwork for developing novel immune profiles and expanding the potential applications of umbilical cord blood in cellular therapy.